Blood cancers, Myelodysplastic syndrome (MDS)
Open
Other
This study is building a record of information about a group of disorders called myelodysplastic syndromes (MDS). The bone marrow is the body’s blood cell factory. In myelodysplastic syndromes (MDS) the bone marrow does not produce enough blood cells. This can lead to problems such as , bleeding or infections. Sometimes, MDS can develop into leukaemia. But the risk of this happening is different for each person.
Recruitment start: 1 April 2008
Recruitment end: 31 December 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Catherine Cargo
European LeukaemiaNet MDS Work Group
Experimental Cancer Medicine Centre (ECMC)
Novartis
University Medical Center Nijmegen St Radboud
Last reviewed: 12 May 2025
CRUK internal database number: 4169